Evidence map›Paper›PMID 25355918›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

CD28-CD80 interactions control regulatory T cell motility and immunological synapse formation.

Timothy J Thauland, Yoshinobu Koguchi, Michael L Dustin, David C Parker

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Timothy J ThaulandDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239; parkerd@ohsu.edu thauland@stanford.edu.
Yoshinobu KoguchiDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239;
Michael L DustinDepartment of Pathology, New York University School of Medicine, New York, NY 10016; and Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7FY, United Kingdom.ORCID http://orcid.org/0000-0003-4983-6389
David C ParkerDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239; parkerd@ohsu.edu thauland@stanford.edu.ORCID http://orcid.org/0000-0003-4456-2788
Oregon Health & Science University · USNuffield Orthopaedic Centre · GB

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
INTERACTIONS AT THE MICROBE/HOST INTERFACET32AI007472 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 1995 to 2019
$6.7M
Requirement for Sensitive T Cell Response to AntigenR37AI043542 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DUSTIN, MICHAEL LORAN · 2007 to 2016
$3.6M
Imaging and Function of the Immunological SynapseR01AI050823 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PARKER, DAVID C · 2002 to 2012
$2.9M
The non-canonical NF-kappaB pathway in survival and function of T lymphocytesR01AI092080 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PARKER, DAVID C · 2011 to 2015
$1.9M
Inflammation and T Lymphocyte ImmunoregulationT32AI078903 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HILL, ANN B · 2009 to 2013
$1.5M
REQUIREMENT FOR SENSITIVE T CELL RESPONSE TO ANTIGENR01AI043542 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DUSTIN, MICHAEL L · 1999 to 2005
$1.5M
NCI NIH HHS P30 CA069533NIAID NIH HHS R01 AI043542NIAID NIH HHS R01 AI050823NIAID NIH HHS R01 AI092080NIAID NIH HHS R37 AI043542NIAID NIH HHS T32 AI007472NIAID NIH HHS T32 AI078903Wellcome Trust 100262
6 · The paper itself

Abstract

Regulatory T cells (Tregs) are essential for tolerance to self and environmental Ags, acting in part by downmodulating costimulatory molecules on the surface of dendritic cells (DCs) and altering naive CD4 T cell-DC interactions. In this study, we show that Tregs form stable conjugates with DCs before, but not after, they decrease surface expression of the costimulatory molecule CD80 on the DCs. We use supported planar bilayers to show that Tregs dramatically slow down but maintain a highly polarized and motile phenotype after recognizing Ag in the absence of costimulation. These motile cells are characterized by distinct accumulations of LFA-1-ICAM-1 in the lamella and TCR-MHC in the uropod, consistent with a motile immunological synapse or "kinapse." However, in the presence of high, but not low, concentrations of CD80, Tregs form stationary, symmetrical synapses. Using blocking Abs, we show that, whereas CTLA-4 is required for CD80 downmodulation, CD28-CD80 interactions are critical for modulating Treg motility in the presence of Ag. Taken together, these results support the hypothesis that Tregs are tuned to alter their motility depending on costimulatory signals.

Indexed as

AnimalsAntigen-Presenting CellsAntigensB7-1 AntigenCD28 AntigensCell CommunicationChemotaxis, LeukocyteDendritic CellsFemaleImmunological SynapsesImmunomodulationMaleMiceMice, TransgenicProtein BindingT-Lymphocytes, RegulatoryAntigensB7-1 AntigenCD28 Antigens

Identifiers

PMID25355918
PMCPMC4258405
OpenAlexW1498495239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.